79 assistant-professor-computer-science-"https:"-"https:"-"https:"-"https:" positions at Center for Drug Evaluation and Research (CDER)

FDA Advanced Evaluation of Postmarket Product Quality Reports

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 12 days ago

that are acceptable for program participation. This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established

FDA High-resolution Analytics Fellowship for Oligonucleotide Therapeutics

Center for Drug Evaluation and Research (CDER) | Saint Louis, Missouri | United States | 12 days ago

activities will entail executing experimental designs, conducting laboratory analyses to help develop analytical methods comprehensively, and gaining insight into drug development and product quality control

FDA Drug Product Quality Assessment

Center for Drug Evaluation and Research (CDER) | Saint Louis, Missouri | United States | 12 days ago

that are acceptable for program participation. This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established

FDA Large Language Models (LLM) for Case Definition Classification Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 12 days ago

safety context. Contribute to the usability testing of the AI-assisted review tool: you will interact with the prototype's user interface to perform assigned tasks, document any issues or challenges, and

FDA Application of AI for Precision Medicine Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 12 days ago

*Applications will be reviewed on a rolling-basis. FDA Office and Location: Multiple research opportunities are available in the Office of Translational Sciences (OTS) / Office of Clinical

FDA Fellowship - Endpoint Strategy Selection and Statistical Analysis Plan for Non-Malignant Hematologic Disease

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 12 days ago

well as Bayesian borrowing can help address sample size and ethical concerns for rare diseases. Collaboration between the statistician at DB9 and the clinical team at the Division of non-malignant hematology to map

FDA Over the Counter (OTC) Drug Product Regulatory Analysis of Antigingivitis/Antiplaque Monograph

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 12 days ago

evaluate the alignment of the current state of basic and applied science with existing antiplaque/antigingivitis monograph regulatory test methods. Under the guidance of the mentor(s), you will help 1

FDA Dosage Optimization of Antibody-Drug Conjugates

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 12 days ago

or late-stage antibody-drug conjugates (ADCs) in the premarket space to aid selection of safe and appropriate dosages of ADCs. The specific aims are to improve our understanding of the current landscape

FDA Risk Assessment of Contaminants for Supply Chain Risks

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 12 days ago

Q9), assessment of volume of excipients used (exposure analysis), and analysis of historical product quality defect trends. Integrating these data, you will help assess potential risks due

FDA Biomarker Qualification Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | 12 days ago

*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is currently available in the Office of New Drugs (OND) / Office of Drug Evaluation Sciences (ODES